Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Profound Medical Q2 EPS $(0.35) Misses $(0.34) Estimate, Sales $1.60M Miss $2.17M Estimate

Author: Benzinga Newsdesk | August 09, 2023 04:56pm
Profound Medical (NASDAQ:PROF) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.34) by 2.94 percent. This is a 225 percent decrease over earnings of $0.28 per share from the same period last year. The company reported quarterly sales of $1.60 million which missed the analyst consensus estimate of $2.17 million by 26.18 percent. This is a 20.89 percent decrease over sales of $2.02 million the same period last year.

Posted In: PROF


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist